NCT04818372 2021-11-12Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and LymphomaKeymed Biosciences Co.LtdPhase 1 Unknown87 enrolled
NCT01750762 2017-04-18Lenalidomide After Allo TransplantDana-Farber Cancer InstitutePhase 1 Terminated1 enrolled